| Control | HBeAg-negative | HBeAg-positive |
---|---|---|---|
Subjects, n | 79 | 73 | 50 |
Demographics | |||
 Age, years | 44 ± 12 | 44 ± 13 | 40 ± 12 |
 Sex, % male | 87% | 85% | 86% |
 Body mass index, kg/m2 | 22.2 ± 2.2 | 22.3 ± 2.1 | 22.1 ± 2.1 |
Lipids profile | |||
 Triglycerides, mmol/L | 1.1 ± 0.41 | 1.72 ± 0.50* | 2.74 ± 0.62#& |
 Total cholesterol, mmol/L | 4.4 ± 0.57 | 3.35 ± 1.33* | 4.12 ± 1.21& |
 HDL-C, mmol/L | 1.35 ± 0.21 | 0.67 ± 0.47* | 0.60 ± 0.36# |
 LDL-C, mmol/L | 2.86 ± 0.53 | 1.96 ± 0.89* | 2.59 ± 1.10& |
 Apolipoprotein A, g/L | 1.38 ± 0.19 | 0.67 ± 0.39* | 0.62 ± 0.34# |
 Apolipoprotein B, g/L | 0.97 ± 0.16 | 0.99 ± 0.44 | 1.24 ± 0.34#& |
 Apolipoprotein M, mg/L | 13.95 ± 7.11 | 52.42 ± 28.09* | 58.32 ± 27.06# |
 Lipoprotein(a), g/L | 102 ± 2.81 | 20.67 ± 3.21* | 26.72 ± 3.73# |
liver biochemical profile | |||
 Alanine aminotransferase, IU/L | 18.25 ± 1.56 | 99.73 ± 4.50* | 216.77 ± 4.17#& |
 Aspartate transaminase, IU/L | 20.11 ± 1.25 | 99.74 ± 2.95* | 171.25 ± 2.80#& |
 Log HBV DNA |  | 4.32 ± 2.03 | 5.61 ± 1.97& |